Juno Therapeutics ^Investors

Juno Therapeutics is a prominent venture capital fund based in Seattle, Washington, founded in 2013 The firm specializes in advancing innovative therapies in the field of immuno-oncology With a significant investment scale of $264,600,000, Juno Therapeutics is dedicated to developing groundbreaking treatments for cancer The organization focuses on harnessing the power of the immune system to provide effective solutions for patients Juno Therapeutics is committed to fostering scientific advancements and improving patient outcomes through strategic investments